[{"id":"1f49581a-ccdf-45d6-b014-9fa49967e11d","acronym":"","url":"https://clinicaltrials.gov/study/NCT00499291","created_at":"2021-01-18T01:47:16.522Z","updated_at":"2024-07-02T16:35:47.102Z","phase":"","brief_title":"Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors","source_id_and_acronym":"NCT00499291","lead_sponsor":"Eastern Cooperative Oncology Group","biomarkers":" CYP2C8","pipe":"","alterations":" ","tags":["CYP2C8"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e albumin-bound paclitaxel"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 09/01/2006","start_date":" 09/01/2006","primary_txt":"","primary_completion_date":"","study_txt":"","study_completion_date":"","last_update_posted":"2023-05-25"}]